2026 Peter B. Bach: Medicine Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Medicine	79	17385	16335	8706	8042	291	30863

Peter B. Bach publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Peter B. Bach sits on this spectrum.

101 publications 1,796+

This scientist: 291 publications — 15th percentile

15% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Peter B. Bach D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Peter B. Bach sits on this spectrum.

70 D-Index 217+

This scientist: 79 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

2016 - Member of the National Academy of Medicine (NAM)
Member of the Association of American Physicians
Member of the Association of American Physicians

Overview

Peter B. Bach is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research primarily spans the fields of Medicine and Economics, Econometrics and Finance, with significant contributions in related subfields such as Economics and Econometrics, Pulmonary and Respiratory Medicine, Oncology, Cancer Research, and Molecular Biology.

The scientist's recent papers reflect a focus on cancer diagnostics, drug trials, and healthcare economics. Notable publications include:

Cell-free DNA approaches for cancer early detection and interception (2023), published in the Journal for ImmunoTherapy of Cancer
Evaluation of Drug Trials in High-, Middle-, and Low-Income Countries and Local Commercial Availability of Newly Approved Drugs (2021), published in JAMA Network Open
Targeting Cancer Lysosomes with Good Old Cationic Amphiphilic Drugs (2020), published in Reviews of Physiology, Biochemistry and Pharmacology
Mapping conflict of interests: scoping review (2021), published in BMJ
Clinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early Detection (2024), published in Cancer Discovery

Their frequent co-authors include Victor E. Velculescu, Aaron Philip Mitchell, Niti U. Trivedi, Robert B. Scharpf, and Joachim Noldus, with multiple collaborations noted.

Peter B. Bach has contributed extensively to several scientific venues, with numerous publications appearing in the Journal of Clinical Oncology, Cancer Research, JAMA Network Open, Journal of the National Comprehensive Cancer Network, and The Oncologist.

The topics covered by their research include:

Health Systems, Economic Evaluations, Quality of Life
Economic and Financial Impacts of Cancer
Cancer Genomics and Diagnostics
Pharmaceutical Economics and Policy
Lung Cancer Diagnosis and Treatment
Pharmaceutical industry and healthcare
Kidney Stones and Urolithiasis Treatments

Among honors awarded to Peter B. Bach are membership in the National Academy of Medicine (NAM) appointed in 2016 and membership in the Association of American Physicians.

Best Publications

Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.

Joan L Warren;Carrie N Klabunde;Deborah Schrag;Peter B Bach

1936
Citations
Benefits and Harms of CT Screening for Lung Cancer: A Systematic Review

Peter B. Bach;Joshua N. Mirkin;Thomas K. Oliver;Christopher G. Azzoli

1462
Citations
Racial differences in the treatment of early-stage lung cancer.

Peter B. Bach;Laura D. Cramer;Joan L. Warren;Colin B. Begg

1186
Citations
Primary care physicians who treat blacks and whites.

Peter B Bach;Hoangmai H Pham;Deborah Schrag;Ramsey C Tate

1108
Citations
A paradigm shift in U.S. Breast reconstruction: increasing implant rates.

Claudia R. Albornoz;Peter B. Bach;Babak J. Mehrara;Joseph J. Disa

1090
Citations
Variations in Morbidity after Radical Prostatectomy

Colin B. Begg;Elyn R. Riedel;Peter B. Bach;Michael W. Kattan

979
Citations
The Influence of Hospital Volume on Survival after Resection for Lung Cancer

Peter B. Bach;Laura D. Cramer;Deborah Schrag;Robert J. Downey

777
Citations
Computed tomography screening and lung cancer outcomes.

Peter B. Bach;James R. Jett;Ugo Pastorino;Melvyn S. Tockman

722
Citations
Variations in Lung Cancer Risk Among Smokers

Peter B. Bach;Michael W. Kattan;Mark D. Thornquist;Mark G. Kris

715
Citations
Care Patterns in Medicare and Their Implications for Pay for Performance

Hoangmai H. Pham;Deborah Schrag;Ann S. O'Malley;Beny Wu

628
Citations
Survival of blacks and whites after a cancer diagnosis.

Peter B. Bach;Deborah Schrag;Otis W. Brawley;Aaron Galaznik

580
Citations
NCCN Task Force Report: Oral chemotherapy.

Saul N. Weingart;Elizabeth Brown;Peter B. Bach;Kirby Eng

576
Citations
Influence of hospital procedure volume on outcomes following surgery for colon cancer.

Deborah Schrag;Laura D. Cramer;Peter B. Bach;Alfred M. Cohen

560
Citations
Age and adjuvant chemotherapy use after surgery for stage III colon cancer.

Deborah Schrag;Laura D. Cramer;Peter B. Bach;Colin B. Begg

560
Citations
Pricing in the Market for Anticancer Drugs

David H. Howard;Peter B. Bach;Ernst R. Berndt;Rena M. Conti

559
Citations
Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Frank C. Detterbeck;Peter J. Mazzone;David P. Naidich;Peter B. Bach

491
Citations
Limits on Medicare's Ability to Control Rising Spending on Cancer Drugs

Peter B. Bach

481
Citations
Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence.

Peter B. Bach;Cynthia Brown;Sarah E. Gelfand;Douglas C. McCrory

443
Citations
The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma.

Nabil P Rizk;Peter B Bach;Deborah Schrag;Manjit S Bains

439
Citations
Hospital and Surgeon Procedure Volume as Predictors of Outcome Following Rectal Cancer Resection

Deborah Schrag;Katherine S. Panageas;Elyn Riedel;Laura D. Cramer

406
Citations

Frequent Co-Authors

Deborah Schrag Harvard University

Colin B. Begg Memorial Sloan Kettering Cancer Center

Katherine S. Panageas Memorial Sloan Kettering Cancer Center

Mark G. Kris Memorial Sloan Kettering Cancer Center

Leonard Saltz Memorial Sloan Kettering Cancer Center

James R. Jett Mayo Clinic

Ernst R. Berndt MIT

Kent A. Sepkowitz Memorial Sloan Kettering Cancer Center

Andrew Briggs University of Glasgow

David Howard Newcastle University

External Links

Wikipedia of Peter B. Bach Personal website of Peter B. Bach

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

The evolving healthcare landscape in the USA has opened up various online education options for students aiming to enter or advance in medical careers. Pursuing an online degree can offer flexibility, affordability, and access to specialized fields outside of traditional medical school.

For those interested in healthcare administration, several cheapest mha programs online healthcare are available, providing essential management skills for leading hospitals and clinics. Similarly, registered nurses looking to reach the highest levels of clinical practice can explore the most affordable dnp programs to earn their Doctor of Nursing Practice online.

Students interested in the pharmaceutical field can now attend pharmacy school online, gaining the credentials for pharmacy licensure through flexible digital study. Likewise, digitization in healthcare has made careers in information management more vital, and a health information technology online degree can prepare graduates for these emerging roles.

These online programs broaden access to diverse healthcare career pathways, allow for study alongside work, and can significantly reduce overall education costs.